MCL
After immigrating to the United State and becoming a U.S. citizen at the age of 18, Holocaust survivor Kurt Glover-Ettrich chose to give back to his new homeland by serving a 30-year career in the U.S. military. Today, as a Mayo Clinic volunteer, Kurt is giving back in new ways for the 22 years of regular care, treatment, and laboratory testing he’s received in response to the prostate cancer diagnosis that first brought him to Mayo Clinic.
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for November include the following sub-specialties: Cardiovascular Pathology, Gastroenterology Pathology, Gynecological Pathology, Laboratory Genetics and Genomics, and Clinical Informatics.
Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, today announced a strategic collaboration to bring Progentec’s suite of proprietary biomarker blood tests for the proactive management of autoimmune diseases to market. The collaboration aims to increase accessibility for providers and patients across the U.S. and select global markets.
In this month's "Hot Topic," Patricia Greipp, D.O., discusses fluorescence in situ hybridization, or FISH testing, particularly related to pediatric patients with hematologic malignancies.
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Timothy Wiltshire, Ph.D., assistant professor of laboratory medicine and pathology in the division of transfusion medicine to discuss what’s new with CAR-T cells.
This page includes updates posted to Mayo Clinic Labs during the month of October.
PACE/State of FL - This “Continual Improvement” webinar provides an overview of the event management process deployed by the Mayo Clinic Department of Laboratory Medicine and Pathology.
PACE / State of FL
In this month’s “Virtual Lecture,” David Murray, M.D., Ph.D., discusses how immunoglobin light chains are used to detect overexpressed immunoglobins which can be applied to distinguish patients with plasma cell disorders and more.
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases.
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Robert Fazzio, M.D., Ph.D., assistant professor of radiology and chair of the Division of Breast Imaging at Mayo Clinic in Rochester, Minnesota.
In a recent discovery by Mayo Clinic Laboratories, a novel hemoglobinopathy category was identified and termed epsilon gamma thalassemia. The first instance of the disorder was found in 2017 when an obstetric patient underwent a routine screening for blood-related illnesses such as sickle cell disease and thalassemia. Upon completion of additional tests, doctors found an abnormality they had never seen before.
In August of 2021, 28-year-old Mike Knudson, a Twin Cities resident known for his vibrant and active lifestyle, set out on what he anticipated to be an adventurous hiking vacation to the picturesque Glacier National Park in Montana. Little did he know that this journey in nature would be the start of an unexpected life path.
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Allan Jaffe, M.D., Wayne and Kathryn Preisel Professor of Cardiovascular Disease Research, Professor of Laboratory Medicine and Pathology, and Professor of Medicine, in the Department of Cardiovascular Diseases at Mayo Clinic to discuss cardiac troponins and checkpoint inhibitors.